Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
Mestag Therapeutics

Mestag Therapeutics

Innovative therapy provider for cancer and inflammatory disease targeting fibroblast-immune interactions.

OverviewStructured DataIssuesContributorsActivity
Is a
Company
Company
Organization
Organization
B2X
B2B
B2B
CEO
Susan Hill
Susan Hill
Country
United Kingdom
United Kingdom
Email Address
bd@mestagtx.com
Founded Date
January 1, 2020
Headquarters
London
London
Industry
Biotechnology
Biotechnology
Health technology
Health technology
Drug discovery
Drug discovery
Investors
Forbion Capital Partners
Forbion Capital Partners
Google Ventures
Google Ventures
INNOVATE UK
INNOVATE UK
Latest Funding Round Date
April 1, 2021
Latest Funding Round Amount (USD)
11,000,000
Latest Funding Type
Seed
Seed
LinkedIn URL
@company/mestag-therapeutics
Location
United Kingdom
United Kingdom
Number of Employees (Ranges)
11 – 50
Total Funding Amount (USD)
13,000,000
Twitter URL
@mestagtx
Official Website
mestagtherapeutics.com

Find more companies like Mestag Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo